Related Experiment Video
Updated: Aug 5, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
The response of eukaryotic topoisomerases to DNA damage
1Department of Biochemistry, 654 Medical Research Building I, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.
Abstract:
Beyond the known mutagenic properties of DNA lesions, recent evidence indicates that several forms of genomic damage dramatically influence the catalytic activities of DNA topoisomerases. Apurinic sites, apyrimidinic sites, base mismatches, and ultraviolet photoproducts all enhance topoisomerase I-mediated DNA cleavage when they are located in close proximity to the point of scission. Furthermore, when located between the points of scission of a topoisomerase II cleavage site, these same lesions (with the exception of ultraviolet photoproducts) greatly stimulate the cleavage activity of the type II enzyme. Thus, as found for anticancer drugs, lesions have the capacity to convert topoisomerases from essential cellular enzymes to potent DNA toxins. These findings raise exciting new questions regarding the mechanism of anticancer drugs, the physiological functions of topoisomerases, and the processing of DNA damage in the cell.
Insights
DNA lesions, such as apurinic sites and base mismatches, significantly alter DNA topoisomerase activity. This interaction can transform these essential enzymes into DNA toxins, impacting cellular DNA repair and drug mechanisms.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- DNA lesions are known mutagens.
- Genomic damage can affect DNA topoisomerase activity.
Purpose of the Study:
- To investigate how various DNA lesions influence DNA topoisomerase I and II activity.
- To explore the implications of these interactions for cellular DNA processing and anticancer drug mechanisms.
Main Methods:
- The study likely involved in vitro assays to measure topoisomerase activity in the presence of different DNA lesions.
- Specific DNA lesions such as apurinic/apyrimidinic sites, base mismatches, and UV photoproducts were analyzed.
Main Results:
- DNA lesions near the cleavage site enhance topoisomerase I activity.
- Lesions between cleavage sites stimulate topoisomerase II activity (except UV photoproducts).
- This suggests DNA lesions can convert topoisomerases into DNA toxins.
Conclusions:
- DNA lesions significantly modulate topoisomerase function.
- This interaction has implications for understanding DNA repair, topoisomerase roles, and anticancer drug action.
- Further research is needed to explore these mechanisms and their therapeutic relevance.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
DNA Damage can Stall the Cell Cycle
Homologous Recombination
DNA Damage Can Stall the Cell Cycle
Inhibitors of Bacterial DNA Synthesis

